{
    "2019-12-16": [
        [
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：6家新投资方拟以可转股权2亿元认缴上海泽润新增注册资本1536.26万美元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新投资方",
                        "可转股权",
                        "上海泽润",
                        "增资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)放弃上海泽润2.6087%股权优先购买权",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "上海泽润",
                        "优先购买权",
                        "放弃"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：放弃上海泽润股权的优先购买权",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "上海泽润",
                        "优先购买权",
                        "放弃"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：新投资方拟以2亿债转股对子公司增资",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新投资方",
                        "债转股",
                        "子公司",
                        "增资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}